A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-Risk, Non-Del(5q) Patients with Myelodysplastic Syndromes: Phase Ib ResultsMikkael A. Sekeres,Hetty E. Carraway,Richard M Stone,Yazan F Madanat,Rami S. Komrokji,Sangeetha Venugopal,Namrata S. Chandhok,Terrence Bradley,Justin Taylor, Anastasia Santiago, Alessia Zoso,Justin M. Watts,Amy E. DeZernBlood（2024）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
